EOM Pharmaceuticals Holdings, Inc.
IMUC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $99 | $278 | $613 | $1,487 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $248 | $131 | $156 | $180 |
| Total Curr. Assets | $347 | $409 | $769 | $1,666 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $43 | $66 | $0 | $0 |
| Total NC Assets | $43 | $66 | $0 | $0 |
| Other Assets | $0 | -$66 | $0 | $0 |
| Total Assets | $390 | $409 | $769 | $1,666 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $442 | $4,366 | $2,847 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $566 | $1,289 | $820 | $465 |
| Total Curr. Liab. | $1,008 | $5,655 | $3,667 | $465 |
| LT Debt | $0 | $369 | $620 | $2,817 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $78 | $670 | $0 |
| Total NC Liab. | $0 | $447 | $1,290 | $2,817 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,008 | $6,102 | $4,957 | $3,282 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $13 | $11 | $11 | $11 |
| Retained Earnings | -$12,859 | -$10,967 | -$9,249 | -$6,602 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $12,228 | $5,263 | $5,049 | $4,975 |
| Total Equity | -$618 | -$5,692 | -$4,189 | -$1,616 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $390 | $409 | $769 | $1,666 |
| Net Debt | $343 | $4,457 | $2,854 | $1,330 |